Fourth AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic

January 4-7, 2016
Hard Rock Hotel
San Diego, California

Conference Chairpersons
Karen L. Kelly, UC Davis Comprehensive Cancer Center, Sacramento, California
Alice T. Shaw, Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Conference Co-Chairpersons
Stephen B. Baylin, Johns Hopkins University School of Medicine, Baltimore, Maryland
Jeffrey A. Engelman, Massachusetts General Hospital, Boston, Massachusetts
Roy S. Herbst, Yale Cancer Center, New Haven, Connecticut
Pierre P. Massion, Vanderbilt University Medical Center, Nashville, Tennessee

Program Committee
Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, New York
Myung-Ju Ahn, Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea
Carolyn R. Aldigé, Prevent Cancer Foundation, Alexandria, Virginia
Nasser K. Altorki, Weill Cornell Medical College, New York, New York
Caroline Dive, CRUK Manchester Institute, Manchester, England
Jessica S. Donington, New York University School of Medicine, New York, New York
Stephen M. Hahn, The University of Texas MD Anderson Cancer Center, Houston, Texas
Quynh-Thu Le, Stanford Cancer Institute, Palo Alto, California
Philip C. Mack, UC Davis Comprehensive Cancer Center, Sacramento, California
Vassiliki A. Papadimitrakopoulou, The University of Texas MD Anderson Cancer Center, Houston, Texas
Julien Sage, Stanford University School of Medicine, Stanford, California
Caicun Zhou, Tongji University, Shanghai Pulmonary Hospital, Shanghai, China

Under the leadership of Margaret Foti, PhD, MD (h.c.), CEO of the American Association for Cancer Research (AACR), and Fred R. Hirsch, MD, PhD, CEO of the International Association for the Study of Lung Cancer (IASLC), we are thrilled to join in our fourth international conference on lung cancer research and treatment. The translational science featured at this conference will include basic research foundation at the bench to patient care in the clinic.  This conference has historically joined a diverse group of attendees (physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research) and provided a venue to discuss recent advances and establish new collaborations. This conference is not only a dynamic collaboration of the AACR and the IASLC, two organizations committed to the study of cancer, but also a dynamic collaboration of the many individuals charged with the study and treatment of this disease.

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available

Gold Supporter:


Silver Supporter:

​Boehringer Ingelheim

Professional Education Grants:

​AstraZeneca​Boehringer Ingelheim

Conference Bag Supporter: